Additionally, in vivo experiments indicate that blocking of PD-1-PD-L1 results in increases of macrophage phagocytosis, reduces tumor growth and prolongs mouse survival in mouse cancer models in a macrophage-dependent manner. Here, PDCD1 is linked to neoplasm.